Recent years have witnessed significant developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://mattielngh843429.isblog.net/exploring-the-future-of-type-2-diabetes-treatment-retatrutide-and-trizepatide-56027466